0002088073-25-000001.txt : 20251015 0002088073-25-000001.hdr.sgml : 20251015 20251015153727 ACCESSION NUMBER: 0002088073-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251015 DATE AS OF CHANGE: 20251015 EFFECTIVENESS DATE: 20251015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: King Therapeutics LLC CENTRAL INDEX KEY: 0002088073 ORGANIZATION NAME: EIN: 994925286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-560923 FILM NUMBER: 251394745 BUSINESS ADDRESS: STREET 1: 12006 S. 44TH ST. CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 9999999999 MAIL ADDRESS: STREET 1: 12006 S. 44TH ST. CITY: PHOENIX STATE: AZ ZIP: 85044 D 1 primary_doc.xml X0708 D LIVE 0002088073 King Therapeutics LLC 12006 S. 44TH ST. PHOENIX AZ ARIZONA 85044 602-516-2199 DELAWARE None None Limited Liability Company true 2024 David Richardson 12006 S. 44th St. Phoenix AZ ARIZONA 85044 Executive Officer Director Chief Executive Officer and Manager of the Issuer Dmitry Derkach 2145 S. Quartz Ct. Gilbert AZ ARIZONA 85295 Director Manager of the Issuer Isaiah Slemons 6411 S. River Dr., Unit 44 Tempe AZ ARIZONA 85283 Director Manager of the Issuer Other Decline to Disclose 06b false 2025-06-11 false true true true Simple Agreement for Future Equity false 0 500000 310000 190000 false 7 0 0 0 false King Therapeutics LLC David Richardson David Richardson Chief Executive Officer and Manager 2025-10-15